Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease erythromelalgia
Symptom C0030193|pain
Sentences 3
PubMedID- 19481586 Microneurographic findings of relevance to pain in patients with erythromelalgia and patients with diabetic neuropathy.
PubMedID- 24278716 Xenon pharmaceuticals reported that, in a pilot study, the nav1.7 blocker xen402 produced marked and significant pain reduction in patients with erythromelalgia .
PubMedID- 23828645 Moreover, a na+-channel blocker has been shown to be effective in relieving spontaneous pain in individuals with erythromelalgia (goldberg et al., 2012).

Page: 1